FDA Warning Letters Released The Weeks Of April 8 And April 15
This article was originally published in The Gray Sheet
Executive Summary
FDA issues warning letters to device manufacturers in Canada, Italy, Japan and the U.S., including Baxter Healthcare Corp.
You may also be interested in...
NANS 2021: Nevro’s HF10 Spinal-Cord Stimulator Succeeds In Two Trials
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.
Warning Letter Roundup & Recap – 19 January 2021
No device-related warning letters were released by the US FDA the week of 19 January.
Start-Up Spotlight: CorWave Takes Inspiration From Nature To Tackle Heart Failure
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: